Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
These reports emphasize markets where technologies intersect with the building blocks of human life, including DNA, RNA, cancer, genomics, genetics, molecular diagnostics and more.
Globally, healthcare constitutes a multi trillion-dollar industry. Reports in this category span the range of treatments, administration practices and technologies available around the world.
Enormously important intersection of engineering, tissue manipulation, the surgeons scalpel and design. Specialist companies target well known and also the barely pronounceable conditions.
The goals of this study are to determine the current market scenario for the global gut-on-a-chip market, estimate the marketâs potential market size by region, and explore the regulatory scenario, applications for healthcare and pharmaceutical companies, the competitive landscape and major competitors. The main objective of the study is to present an analysis of the current gut-on-a-chip market and the future directions.
The global market for implantable remote patient monitoring devices reached $2.8 billion in 2018 and should reach $10.1 billion by 2025, at a compound annual growth rate (CAGR) of 20.1% for the period of 2018-2025.
The goal of this report is to understand the current digital therapeutics scenario and to assess the market’s growth potential. This study explores market dynamics that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market and the future direction of the market.
The global market for agricultural biotechnology products should grow from $50.5 billion in 2019 to $72.2 billion by 2024 with a compound annual growth rate (CAGR) of 7.4% for the period of 2019-2024.
This report presents a comprehensive discussion of smart biopsy devices, along with current and future commercial potential for each key market segment. It outlines the key industry segments and market trends along with quantification of main market potential.
The global market for cloud computing applications in cell biology, genomics and drug development should grow from $2.2 billion in 2019 to $6.4 billion by 2024, with a compound annual growth rate (CAGR) of 23.4% during the period of 2019-2024.
AI is impacting many sectors, including healthcare. Within this sector AI is providing breakthrough in diagnostics, therapeutics, patients recovery time and outcomes, and health management. AI is being applied in the diagnosis and treatment of various medical conditions, in particular to solve some of the critical issues related to hard-to-cure diseases, such as Alzheimer’s (AD). This report summarizes the most relevant applications of artificial intelligence in AD and the various categories of supervised learning algorithms used in Alzheimer’s and their applications.
The Asia-Pacific genomics and proteomics tools market should reach $5.9 billion by 2023 from $4.0 billion in 2019 at a compound annual growth rate (CAGR) of 10.4% for the forecast period of 2019 to 2023.
The goals of this study were to understand the regulations and requirements of the companies in the US and the foreign companies or establishments planning to manufacture, distribute or market their medical devices in the US. This report provides a brief about the related regulation for registration of the establishments or medical devices along with the classification of the devices.
The global stress management treatments market should reach $20.6 billion by 2024 from $17.2 billion in 2019 at a compound annual growth rate (CAGR) of 3.7% for the forecast period of 2019 to 2024.
The goals of this study were to understand the current market scenario for congenital heart defect devices in the U.S. and to determine the market's growth potential over the period from 2018 through the end of 2035. The study explores market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. The main objective of this report is to present a comprehensive analysis of the current market for congenital heart defect devices in the U.S.
The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.
According to the National Science Foundation (NSF) the term nano refers to particles, structures, or devices having at least one dimension below 100 nm. Development, manufacturing and sale of these products have spawned a multibillion industry, commonly referred to as the nanotechnology sector. This report gives a market outlook of nanotechnology in cancer treatment and provides information on its most relevant applications. The major trends, issues and recent achievements in nanotechnology-based cancer treatment are also discussed.
The global viscosupplementation market should grow from $3.2 billion in 2018 to $5.9 billion by 2025 at compound annual growth rates (CAGR) of 9.0% for the period of 2018-2025.
The global animal therapeutics and diagnostics market should grow from $49.9 billion in 2019 to $66.5 billion by 2024 with a compound annual growth rate (CAGR) of 5.9% for the period of 2019-2024.
The hyperkalemia market is currently a flourishing market, with a strong drug pipeline and upcoming technologies for the diagnosis of conditions. This report on Hyperkalemia Market highlights market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. BCC Research focuses on the comprehensive analysis of the current market for hyperkalemia and the future direction of the market.
This report on Medical Affairs highlights overall growth due to rapidly changing pharmaceutical and medical device markets by forming new paradigms and employing marketing strategies that increase market share. The research will provide information on leading market competitors, their market share, partnerships, collaborations, mergers and acquisitions between pharmaceutical companies. BCC Research focuses on the importance of medical affairs in communicating and collecting the medical evidence with the organization and external stakeholders.
The goal of this short study is to help companies operating within the life science sector gain valuable insights on bioinks by providing an overview of types, compositions, and applications of bioinks. This report outlines the trends that are expected to contribute to market growth for these materials.
This comprehensive report provides an in-depth assessment of the global market for non-injectable insulin. The report's key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of non-injectable insulin in developed and emerging markets.
The global induced pluripotent stem cells (iPSC) market should reach $3.8 billion by 2024 from $2.4 billion in 2019 at a compound annual growth rate (CAGR) of 9.2% for the forecast period of 2019 to 2024.
The goals of this study were to understand the current market scenario for Blockchain technology in Healthcare and to access the market’s growth potential over the five-year period from 2018 through the end of 2023. The study explores market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market for Blockchain technology and the future direction of the market in healthcare.
The global market for non-opioid pain treatments should grow from $13.8 billion in 2019 to $31.8 billion by 2024 at a compound annual growth rate (CAGR) of 18.3% for the period of 2019-2024.
The global market for sample preparation in genomics, proteomics and epigenomics should grow from $6.1 billion in 2019 to $7.8 billion by 2024 at a compound annual growth rate (CAGR) of 5.3% during 2019-2024.
The global proton therapy market for cancer reached $671.6 million in 2019 and should reach $1.2 billion by 2024, at a compound annual growth rate (CAGR) of 13.1% for the period of 2019-2024.
The global market for blockchain technology in healthcare applications should grow from $140.0 million in 2019 to $1.4 billion by 2024 at a compound annual growth rate (CAGR) of 58.2% during the forecast period, 2019-2024.
Report will forecast current and future trends in health and weight management space and its potential market for 2020-2025.
Get an outlook on the HTA process and its approvals in major pharma industries.
This report provides an overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline of animal, human and other organisms
Get an overview of the current state of the art for Continuous Glucose Monitoring (CGM) for diabetes.
- An overview of R&D, economic impact and future implications for global market due to COVID-19
- Coverage of therapies which are currently being produced and clinical trials of vaccines for COVID-19
- Insights into key scientific breakthroughs and developments that are underway right now
- Information on scientific studies on previously approved medicines that could treat this infection
The report will provide details about the pain management drugs used in the form of patches for immediate relief from any type of pain.
The current report provides detailed exposure to the sternal closure devices market.
The current report provides detailed competitive landscape of top 100 medical device manufacturers in the global market.
Examine 3D cell cultures technologies with current market status, future market drivers and its growth potential over the five-year period from 2019 to 2024.
This report provides comprehensive analysis of biologics, or biopharmaceuticals, on a global basis. it also gives information, from detailed product analyses within disease subsegments to overall industry trends.
Get a comprehensive view of the global markets for natural language processing (NLP) in healthcare industry.
Get an overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics. Analyses of global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024.
An overview of the global markets for pharmaceuticals, specifically healthcare legislation and regulation, pricing mechanisms, and reimbursement procedures.
This report evaluates the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. it also provides information on the current market dynamics and factors influencing the future growth opportunities in the antifungal drugs market.
Get an analysis of the advanced drug delivery market by technology systems, applications, routes of administration, and drug delivery vehicles.
Get an overview of the global markets and technologies for rare disease diagnostics and discussion on market opportunities for these technologies.
Detailed review of artificial intelligence (AI) applications in the diagnosis and treatment of cancer diseases. Coverage of different AI algorithm types -- artificial neural networks and deep learning -- and their feasible healthcare applications in the field of cancer
Get an overview of global market for cell and gene therapy tools and information on their importance in treating human health.
An overview of the artificial intelligence (AI) applications in fighting against HIV/AIDS-related illnesses. Discussion of recent achievements and breakthrough therapies related to HIV/AIDS disease segments.
PCR for POC Diagnostics
BCC Research analyst Todd Graham delves into the markets being served by the new technology for polymerase chain reaction for point-of-care diagnostics, sharing the uses, outlook, and more on these clinical diagnostic kits. Recorded live on May 16, 2018.
How to Dissect a Market Opportunity
BCC Research Senior Editor Gordon Nameni shares how to interpret market research to uncover market opportunities at a live event on September 12, 2017, in Boston, MA.